These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24461763)

  • 1. COPD patients trapped in the financial crisis in rural Crete.
    Tsiligianni IG
    Lancet Respir Med; 2013 Dec; 1(10):e31-2. PubMed ID: 24461763
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic burden of chronic obstructive pulmonary disease.
    Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.
    Bilde L; Rud Svenning A; Dollerup J; Baekke Borgeskov H; Lange P
    Respir Med; 2007 Mar; 101(3):539-46. PubMed ID: 16889949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol.
    van Boven JF; Román-Rodríguez M; Kocks JW; Soriano JB; Postma MJ; van der Molen T
    NPJ Prim Care Respir Med; 2015 Aug; 25():15051. PubMed ID: 26247130
    [No Abstract]   [Full Text] [Related]  

  • 6. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K; Targowski T; From S; Faluta T; Borowiec L
    Pneumonol Alergol Pol; 2011; 79(5):337-42. PubMed ID: 21861257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of the financial crisis on outpatient hospital visits due to otorhinolaryngologic disorders in Crete, Greece.
    Karatzanis AD; Symvoulakis EK; Nikolaou V; Velegrakis GA
    Int J Med Sci; 2012; 9(2):126-8. PubMed ID: 22253558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer.
    Au DH; Udris EM; Fihn SD; McDonell MB; Curtis JR
    Arch Intern Med; 2006 Feb; 166(3):326-31. PubMed ID: 16476873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
    Miravitlles M; Sicras A; Crespo C; Cuesta M; Brosa M; Galera J; Lahoz R; Lleonart M; Riera MI
    Ther Adv Respir Dis; 2013 Jun; 7(3):139-50. PubMed ID: 23653458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.
    Hutchinson A; Brand C; Irving L; Roberts C; Thompson P; Campbell D
    Intern Med J; 2010 May; 40(5):364-71. PubMed ID: 20180870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the costs of managing patients with chronic obstructive pulmonary disease.
    Mapel DW; McMillan GP; Frost FJ; Hurley JS; Picchi MA; Lydick E; Spencer MD
    Respir Med; 2005 Oct; 99(10):1325-33. PubMed ID: 16140232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estimation of direct medical costs of chronic obstructive pulmonary disease over 12 months].
    Stâmbu I; Stoicescu IP
    Pneumologia; 2013; 62(2):86-92. PubMed ID: 23894789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COPD: illness severity, resource utilisation and cost.
    Tynan AJ; Lane SJ
    Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart BC; Simoni-Wastila L; Zuckerman IH; Davidoff A; Shaffer T; Yang HW; Qian J; Dalal AA; Mapel DW; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):441-53. PubMed ID: 21335297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
    Jahnz-Rózyk K; Targowski T; From S; Płusa T
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of chronic obstructive pulmonary disease treatment].
    Targowski T; Jahnz-Rózyk K
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():86-7. PubMed ID: 15524026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global initiative for chronic obstructive lung disease for chronic obstructive pulmonary disease: GOLD opportunity for lung disorders.
    Minas M; Dimitropoulos K; Pastaka Ch; Papadopoulos D; Markoulis N; Gourgoulianis KI
    Prev Med; 2005 Mar; 40(3):274-7. PubMed ID: 15533539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs.
    Jensen MB; Fenger-Grøn M; Fonager K; Omland Ø; Vinding AL; Hansen JG
    Dan Med J; 2013 Jan; 60(1):A4557. PubMed ID: 23340185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma.
    Rhee CK; Yoon HK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Kim Y; Kim K; Kim J; Oh YM; Lee SD
    COPD; 2014 Apr; 11(2):163-70. PubMed ID: 24111662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.